Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 734 | 962 | 1,202 | 1,116 | 1,426 |
| Operating Income | -734 | -962 | -1,202 | -1,116 | -1,426 |
| Interest Expense | 711 | 683 | 657 | 639 | 635 |
| Other Income | 6,278 | 0 | 0 | 1 | 1 |
| Pre-tax Income | 4,833 | -1,644 | -1,859 | -1,754 | -2,060 |
| Net Income Continuous | 4,833 | -1,644 | -1,859 | -1,754 | -2,060 |
| Net Income | $4,833 | $-1,644 | $-1,859 | $-1,754 | $-2,060 |
| EPS Basic Total Ops | 750.00 | -300.00 | -350.00 | -350.00 | -450.00 |
| EPS Basic Continuous Ops | 893.18 | -303.78 | -363.47 | -346.61 | -442.01 |
| EPS Diluted Total Ops | 650.00 | -300.00 | -350.00 | -350.00 | -450.00 |
| EPS Diluted Continuous Ops | 756.22 | -303.78 | -363.47 | -346.61 | -442.01 |
| EBITDA(a) | $-717 | $-934 | $-1,186 | $-1,100 | $-1,410 |